Private practices face different informatics challenges than larger institutions, but Adam H. Kaye, MD, with Advanced Radiology Consultants in Bridgeport, Connecticut, believes there are a number of areas radiologists can focus on to show value to the institution and drive profits.

Several aspects of cancer-related cognitive impairment are currently unknown, including why it occurs, how long it lasts and what other health problems it causes. But the real mystery lies in the wide-ranging estimates of how many cancer patients “chemobrain” actually impacts, according to an article in the Los Angeles Times.

A multicenter clinical trial underway at UT Southwestern in Dallas is testing a new technique that would avoid nerve bundles and arteries commonly affected during prostate cancer radiation therapy in hopes of preserving patients’ sexual function.

CT angiography (CTA), coupled with fractional flow reserve (FFR), demonstrated an ability to detect functionally significant lesions in patients with multivessel coronary artery disease (CAD).

GE Healthcare named Tom McGuinness its new president and CEO of GE Healthcare's Imaging business on June 11, according to an internal report from GE Healthcare.

Chris Roth, MD, PhD and vice chair of information technology and clinical informatics at Duke University Medical Center once led a enterprise imaging initiative that resulted in hard times for the hospital and himself—but he helped implement a governance strategy so his mistakes are never repeated.

With the help of advanced CT imaging, researchers from the Netherlands found that smokers and individuals with diabetes may face an increased risk of developing calcifications in the hippocampus, the region of the brain responsible for memory.

Children with chronic kidney disease may have an increased risk of cognitive impairment due to major blood flow changes occurring in the brain, according to research published June 12 in Radiology.

Cancer researchers are taking notice of a pair of studies published in Nature Medicine that found editing a cell’s genomes with CRISPR-Cas9 has the potential to seed cancer and may eventually generate the disease, STAT reports.

Intrinsic susceptibility biomarkers were found to successfully provide cross validation of the oxygen-enhanced MRI biomarker perfused Oxy-R when mapping tumor hypoxia in renal carcinoma, according to research published in Radiology.